Drug Shortage Report for MAR-MONTELUKAST
Report ID | 206808 |
Drug Identification Number | 02399997 |
Brand name | MAR-MONTELUKAST |
Common or Proper name | Montelukast |
Company Name | MARCAN PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | MONTELUKAST |
Strength(s) | 10MG |
Dosage form(s) | TABLET TABLET |
Route of administration | ORAL ORAL |
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
Additional packaging sizes | 30 |
ATC code | R03DC |
ATC description | OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2023-10-01 |
Actual start date | 2023-10-11 |
Estimated end date | 2024-10-31 |
Actual end date | 2024-11-15 |
Shortage status | Resolved |
Updated date | 2025-04-28 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2 GURDWARA RD., SUITE 112 OTTAWA, ONTARIO CANADA K2E 1A2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2025-04-28 | French | Compare |
v5 | 2025-04-28 | English | Compare |
v4 | 2023-10-12 | English | Compare |
v3 | 2023-10-11 | French | Compare |
v2 | 2023-10-11 | English | Compare |
v1 | 2023-10-11 | English | Compare |
Showing 1 to 6 of 6